World-first Scalp Cooling Summit unites industry leaders to discuss future of supportive cancer care

The world’s first Scalp Cooling Summit will unite global oncology and research thought leaders to discuss current practice and how to advance the future of scalp cooling and side effect management in cancer care.

Taking place digitally on the 5th May 2022, this first of its kind Summit will deliver keynote discussions and roundtables led by innovative world leaders in oncology and research and live Q&A sessions.

The Summit’s aim is to provide a virtual space to inspire those working in oncology to see the importance and potential of scalp cooling in individual symptom management, and provide them the tools to implement better scalp cooling in their practice.

The free-to-attend international event is open to all oncology healthcare professionals globally, and will provide attendees with the opportunity to collaborate with other delegates via open forums, networking halls, and drop-in sessions with the keynote speakers.

The day will explore a range of topics including:

  • the impact of persistent chemotherapy-induced alopecia as a result of docetaxel
  • how scalp cooling can limit the psychosocial impact of hair loss on patients
  • the role of onco-dermatology in a patient’s treatment journey
  • the importance of equity in side effect management

46 speakers from a spectrum of disciplines and institutions, experts in their professional field and patient advocates will be joining the event virtually from all over the globe, to explore the future of supportive cancer care. Speakers include President Elect of the Multinational Association of Supportive Care in Cancer (MASCC) Dr Maryam Lustberg; Dr Mario Lacouture, Dr Julie Nangia, Maimah Karmo, founder of Tigerlily Foundation; Dr Stephanie Graff, Dr Amy Comander, Dr Charles Loprinzi and Dr Corina van den Hurk.

Following the event the Summit will become a long-term educational platform where all content will be available to delegates on-demand, to allow them to revisit or explore in greater detail at a time convenient to them.

It is being supported by the UK Association of Supportive Care in Cancer, The International Society of Nurses in Cancer Care and The Japanese Association of Supportive Care in Cancer.

Richard Paxman, CEO of Paxman said: “The Scalp Cooling Summit is a world-first event that aims to push the boundaries of side effect management in cancer care. We are delighted to be bringing together global pioneers to explore new ideas and embark in open and honest discussions on how to progress precision side effect management and advance scalp cooling. The event features a thought-provoking agenda and aims to provide an unrivalled platform for delegates to network with and learn from their peers, inspire conversation, and challenge perspectives.”

Scalp cooling is a pioneering technology designed to help maintain the quality of life for cancer patients facing chemo-induced hair loss. The novel treatment provides cancer patients with the only real alternative to this devastating side effect, which can often be an unwanted reminder of their disease and can compromise their self-image.

The simple treatment involves patients wearing a ‘cold cap’ which works by reducing the temperature of the scalp by a few degrees immediately before, during and after the administration of chemotherapy. This in turn reduces the blood flow carrying chemotherapy drugs to hair follicles, which can prevent or minimise hair loss.

The virtual Scalp Cooling Summit will be taking place on 5th May 2022, 9:00am –5:00pm BST (Extended agenda 5:00pm – 11:15pm BST). To view the UK/Europe agenda and to register as a delegate for free, visit


Join our audience of healthcare industry professionals

Join our audience of healthcare industry professionals